HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

9-O-methanoprostaglandin I

shows weak inhibitory activity in rabbit platelet aggregation induced by ADP; RN given refers to cpd without isomeric designation
Also Known As:
9-O-methano-6 beta-PGI1; 9-O-methano-PGI1; 9-O-methanoprostaglandin I, 3aR-(3aalpha,5beta,6alpha(1E,3S*),6aalpha)-isomer; 9-O-methanoprostaglandin I, 3aS-(3aalpha,5beta,6alpha(1Z,3R*),6aalpha)-isomer; TEI 7165; TEI-7165; isocarbacyclin
Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Nakaike, Shiro: 2 articles (04/2003 - 08/2002)
2. Araki, Hiroaki: 2 articles (04/2003 - 08/2002)
3. Karasawa, Yasuko: 2 articles (04/2003 - 08/2002)
4. Komiyama, Hiroko: 2 articles (04/2003 - 08/2002)
5. Yoshida, Shigeru: 2 articles (04/2003 - 08/2002)
6. Katsuura, Yasuhiro: 1 article (04/2003)
7. Hino, Noriko: 1 article (04/2003)
8. Kobayashi, Tsunefumi: 1 article (08/2002)
9. Isobe, Yoshihiko: 1 article (08/2002)
10. Hitomi, Takehiko: 1 article (08/2002)

Related Diseases

1. Ischemia
2. Stroke (Strokes)
3. Brain Ischemia (Cerebral Ischemia)
4. Cerebral Infarction

Related Drugs and Biologics

1. Epoprostenol (Prostacyclin)
2. TTC 909
3. TEI 9090 (clinprost)
4. 9-O-methanoprostaglandin I

Related Therapies and Procedures

1. Microspheres (Microsphere)